T. Rowe Price Investment Management, Inc. - REPARE THERAPEUTICS INC ownership

REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 75 filers reported holding REPARE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.7%.

Quarter-by-quarter ownership
T. Rowe Price Investment Management, Inc. ownership history of REPARE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$21,707
+7.8%
1,796,906
-5.6%
0.02%
+7.1%
Q2 2023$20,136
+7.0%
1,903,206
-0.5%
0.01%
+7.7%
Q1 2023$18,818
-33.3%
1,912,351
-0.3%
0.01%
-40.9%
Q4 2022$28,215
-99.9%
1,918,026
+8.8%
0.02%
+29.4%
Q3 2022$21,383,0001,762,7430.02%
Other shareholders
REPARE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,242,636$22,067,5389.20%
CHI Advisors LLC 2,997,939$29,499,7197.83%
MPM BioImpact LLC 1,639,849$16,136,1144.19%
BVF INC/IL 8,291,988$81,593,1622.98%
HighVista Strategies LLC 164,890$1,622,5181.32%
Sio Capital Management, LLC 228,538$2,248,8141.11%
Deep Track Capital, LP 2,727,606$26,839,6431.10%
Redmile Group, LLC 2,533,050$24,925,2121.08%
Orbimed Advisors 3,322,488$32,693,2820.64%
Artal Group S.A. 700,000$6,8880.41%
View complete list of REPARE THERAPEUTICS INC shareholders